Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT00950365 |
| Title | Pharmacodynamic Separation of Pemetrexed and Erlotinib as Second-line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Montefiore Medical Center, Eli Lilly and Company, OSI Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California Davis Comprehensive Cancer Center | Sacramento | California | 95817 | United States | Details | |
| University of Massachusetts Memorial Health Care | Worcester | Massachusetts | 01605 | United States | Details | |
| Albert Einstein College of Medicine | Bronx | New York | 10461 | United States | Details | |
| Bronx River Medical Associates PC | Bronx | New York | 10467 | United States | Details | |
| Eastchester Center for Cancer Care | Bronx | New York | 10469 | United States | Details |